Nature's Sunshine Products, Inc. (NATR)
NATRNASDAQ-CMBiotechnology: Pharmaceutical Preparations
$10.93
-0.0900 (-0.82%) today
At the close, Nov 10, 4:00 PM ET. After hours $10.93 –
- Market cap
- $189.40m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $10.86 to $11.61
- 52-week range
- $9.38 to $28.14
- Average volume
- 155.5k
- Previous close
- $11.02
Analysts
2 coveringStrong Buy2 buy, 0 hold, 0 sell
Targets a year out average $16.50, +51.0% from here
Earnings
Next report
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $128.34m | $123.81m | $122.89m | $116.98m |
| Gross profit | $94.05m | $89.78m | $89.98m | $86.17m |
| Operating income | $8.97m | $5.32m | $9.54m | $5.48m |
| Net income | $5.33m | $4.11m | $5.12m | $3.54m |
Last four quarters: revenue $492.02m, margin 3.7%, free cash flow $18.09m
News
8 latest- Nature's Sunshine (NATR) Q3 2026 Earnings Call TranscriptThe Motley Fool · 5 days ago
- What Nature's Sunshine Products (NATR) Said on Its Q3 Earnings CallMarketBeat · 6 days ago
- Nature’s Sunshine Targets $1B Sales, 15% EBITDA Margin in Growth PushMarketBeat · Aug 15, 2026
- Nature's Sunshine (NATR) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 14, 2026
- Nature's Sunshine Products Q2 Earnings Call HighlightsMarketBeat · Aug 7, 2026
- Nature's Sunshine Products Q1 Earnings Call HighlightsMarketBeat · May 8, 2026
- NATR Q1 2026 Earnings TranscriptThe Motley Fool · May 7, 2026
- Nature's Sunshine Products (NATR) Price Target Increased by 46.67% to 33.66Fintel · Mar 26, 2026
The company
Nature's Sunshine Products (Nasdaq: NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature's Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety, and efficacy on the market today. Additional information about the company can be obtained at its website, www.naturessunshine.com.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- natr.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.